JV-GL1 / JeniVision - LARVOL DELTA

Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension (clinicaltrials.gov) - P1/2 | N=70 | Suspended | Sponsor: JeniVision, Inc. | Trial completion date: Jul 2023 ➔ Jul 2025 | Active, not recruiting ➔ Suspended | Trial primary completion date: Mar 2023 ➔ Mar 2025

Trial completion date • Trial primary completion date • Trial suspension • Cardiovascular • Glaucoma • Ophthalmology

Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension (clinicaltrials.gov) - P1/2 | N=70 | Active, not recruiting | Sponsor: JeniVision, Inc. | Recruiting ➔ Active, not recruiting | Trial completion date: Jul 2022 ➔ Jul 2023 | Trial primary completion date: Dec 2021 ➔ Mar 2023

Enrollment closed • Trial completion date • Trial primary completion date • Glaucoma • Ophthalmology